Search - tctmd.com

Displaying 201 - 220 of 456

Sort: Relevancy | Date

News Industry News

Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease

April 11, 2018

News Daily News

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

Caitlin E. Cox

January 11, 2018

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

Presentation TCT 2017

TCT 48: Potential Intraplaque Hemorrhage Pattern Assessed by Combined Intravascular Ultrasound and Optical Coherence Tomography

Presenter: John McB. Hodgson, Akiko Maehara, Tetsumin Lee, MD

October 31, 2017

Presentation TCT 2017

TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry

Presenter: Francesco Prati, Renu Virmani, Yoshinori Nagasawa, MD

October 31, 2017

Presentation TCT 2017

TCT 47: Morphological Difference of Culprit Lesions by Age and Gender Assessed by Optical Coherence Tomography

Presenter: John McB. Hodgson, Akiko Maehara, Mitsuaki Matsumura, MD

October 31, 2017

Presentation TCT 2017

TCT 28: A New Optical Coherence Tomography-Based Calcium Scoring System to Predict Stent Underexpansion

Presenter: Ehrin J. Armstrong, Gert Richardt, Akiko Fujino, MD

October 31, 2017

Presentation TCT 2017

TCT 42: LONG-TERM CONSEQUENCES of Optical coherence tomography FINDINGS DURING PERCUTANEOUS CORONARY INTERVENTION: The Centro per la Lotta contro lInfarto - Optimization of Percutaneous Coronary Intervention (CLI-OPCI) LATE Study

Presenter: Ulf Landmesser, Bernhard Witzenbichler, Enrico Romagnoli, MD

October 31, 2017

Presentation TCT 2017

TCT 26: Orbital Atherectomy Induced Calcium Fracture Facilitates Stent Expansion - An Optical Coherence Tomography Study

Presenter: Ehrin J. Armstrong, Gert Richardt, Myong Hwa Yamamoto, MD

October 31, 2017

Presentation TCT 2017

TCT 10: Mechanisms of Very Late Bioresorbable Scaffold Thrombosis Assessed by Optical Coherence Tomography - Insights From the International INVEST Registry

Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Lorenz Raber

October 31, 2017

Presentation TCT 2017

TCT 41: Initial Pre-clinical Porcine and Ex-Vivo Human Coronary Images With a Hybrid Intravascular Ultrasound and Optical Coherence Tomography System

Presenter: Ulf Landmesser, Bernhard Witzenbichler, Brian Courtney, MD

October 31, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

Real-World STEMI Study Shows Low Rate of Early Stent Thrombosis After Primary PCI

Todd Neale

July 28, 2017

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Conference News EuroPCR 2017

Slimmest Stent to Date Looks Promising in Small Study

Shelley Wood

May 19, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Industry News

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

May 16, 2017

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

News Daily News

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

Caitlin E. Cox

May 15, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

Advertisement

Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

TCT 48: Potential Intraplaque Hemorrhage Pattern Assessed by Combined Intravascular Ultrasound and Optical Coherence Tomography

TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry

TCT 47: Morphological Difference of Culprit Lesions by Age and Gender Assessed by Optical Coherence Tomography

TCT 28: A New Optical Coherence Tomography-Based Calcium Scoring System to Predict Stent Underexpansion

TCT 42: LONG-TERM CONSEQUENCES of Optical coherence tomography FINDINGS DURING PERCUTANEOUS CORONARY INTERVENTION: The Centro per la Lotta contro lInfarto - Optimization of Percutaneous Coronary Intervention (CLI-OPCI) LATE Study

TCT 26: Orbital Atherectomy Induced Calcium Fracture Facilitates Stent Expansion - An Optical Coherence Tomography Study

TCT 10: Mechanisms of Very Late Bioresorbable Scaffold Thrombosis Assessed by Optical Coherence Tomography - Insights From the International INVEST Registry

TCT 41: Initial Pre-clinical Porcine and Ex-Vivo Human Coronary Images With a Hybrid Intravascular Ultrasound and Optical Coherence Tomography System

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Real-World STEMI Study Shows Low Rate of Early Stent Thrombosis After Primary PCI

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Slimmest Stent to Date Looks Promising in Small Study

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content